Piomic Medical is a rapidly growing international medical device company based in Zurich, Switzerland, with a dedicated subsidiary in the Chicago metro area. The company specializes in innovative treatments for hard-to-heal wounds, particularly through its proprietary COMS® One therapy, which combines optical and magnetic stimulation to enhance the healing of chronic ulcers. With CE Mark Approval received in 2020, Piomic is preparing to enter the U.S. market following a robust clinical trial for diabetic foot ulcers. The company is committed to expanding its product portfolio through ongoing research and development, aiming to improve the quality of life for patients suffering from debilitating chronic ulcers.